GLOBUS MEDICAL, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
GLOBUS MEDICAL, INC. (GMED) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $32.29 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $32.29M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $41.08M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $39.72M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $20.55M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $32.29M 10-K · filed 2026-02-24 |
| 2024-12-31 | $41.08M 10-K · filed 2026-02-24 |
| 2023-12-31 | $39.72M 10-K · filed 2025-02-20 |
| 2022-12-31 | $20.55M 10-K · filed 2024-02-21 |
| 2021-12-31 | $16.17M 10-K · filed 2023-02-21 |
| 2020-12-31 | $14.30M 10-K · filed 2022-02-17 |
| 2019-12-31 | $14.02M 10-K · filed 2021-02-17 |
| 2018-12-31 | $10.96M 10-K/A · filed 2020-03-02 |
| 2017-12-31 | $9.11M 10-K · filed 2019-02-21 |
| 2016-12-31 | $10.60M 10-K · filed 2018-02-22 |
| 2015-12-31 | $8.01M 10-K · filed 2017-03-16 |
| 2014-12-31 | $5.55M 10-K · filed 2016-02-29 |
| 2013-12-31 | $5.15M 10-K · filed 2015-02-26 |
| 2012-12-31 | $4.91M 10-K · filed 2014-03-14 |
| 2011-12-31 | $3.84M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |